1. Heller, Scott A, Shih, Renata, Kalra, Raghav, Kang, Peter B. 2019. Emery-Dreifuss muscular dystrophy. In Muscle & nerve, 61, 436-448. doi:10.1002/mus.26782. https://pubmed.ncbi.nlm.nih.gov/31840275/
2. Wang, Jun, Huang, Fang, Huang, Jian, Liu, Shenglan, Jin, Jun. 2017. Epigenetic analysis of FHL1 tumor suppressor gene in human liver cancer. In Oncology letters, 14, 6109-6116. doi:10.3892/ol.2017.6950. https://pubmed.ncbi.nlm.nih.gov/29113254/
3. Cao, Zhiwen, Yan, Qiang, Zhang, Mei, Sun, Haixiang, Yan, Guijun. 2022. FHL1 mediates HOXA10 deacetylation via SIRT2 to enhance blastocyst-epithelial adhesion. In Cell death discovery, 8, 461. doi:10.1038/s41420-022-01253-5. https://pubmed.ncbi.nlm.nih.gov/36418297/
4. Megarbane, Andre, Bizzari, Sami, Deepthi, Asha, Delague, Valérie, Urtizberea, J Andoni. . A 20-year Clinical and Genetic Neuromuscular Cohort Analysis in Lebanon: An International Effort. In Journal of neuromuscular diseases, 9, 193-210. doi:10.3233/JND-210652. https://pubmed.ncbi.nlm.nih.gov/34602496/
5. Gueneau, Lucie, Bertrand, Anne T, Jais, Jean-Philippe, Ben Yaou, Rabah, Bonne, Gisèle. 2009. Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy. In American journal of human genetics, 85, 338-53. doi:10.1016/j.ajhg.2009.07.015. https://pubmed.ncbi.nlm.nih.gov/19716112/
6. Chen, Junxin, Zeng, Chuimian, Jin, Jiewen, Li, Yanbing, Guan, Hongyu. 2024. Overexpression of FHL1 suppresses papillary thyroid cancer proliferation and progression via inhibiting Wnt/β-catenin pathway. In Endocrine, 85, 238-249. doi:10.1007/s12020-023-03675-2. https://pubmed.ncbi.nlm.nih.gov/38191984/
7. Lim, Ka Young, Kim, Hyun Hee, Sung, Jung-Joon, Kim, Keewon, Park, Sung-Hye. 2019. FHL1-mutated reducing body myopathy. In Neuropathology : official journal of the Japanese Society of Neuropathology, 40, 185-190. doi:10.1111/neup.12619. https://pubmed.ncbi.nlm.nih.gov/31803991/
智鼠故事 
